Abstract
Inhibitory GABAA receptor modulators are widely used therapeutic agents for a variety of central nervous system disorders. Ltk– cells stably expressing human recombinant GABAA subunits (α1β1–3γ2s) were seeded into 96-well plates, loaded with chlorocoumarin-2-dimyristoyl phosphatidylethanolamine and bis(1,3-diethyl-2-thiobarbiturate)trimethineoxonol, and rapid fluorescence resonance energy transfer technique (FRET) measurements were made of GABA-evoked depolarizations in low-Cl– buffer using a voltage/ion probe reader. The influence of different βsubunits on the ability of agents to modulate and directly activate the ion channel was examined. GABA evoked concentration-dependent decreases in FRET, increasing fluorescence emission ratio (460/580 nm) at α1β1γ2, α1β2γ2, and α1β3γ2 receptors with similar maximal amplitude (P > 0.05, n = 17) and EC50 values of 2.4 ± 0.2, 2.5 ± 0.2, and 1.3 ± 0.1 μM, respectively. Piperidine-4-sulfonic acid and 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol were less potent, with EC50 values of 8.7 ± 0.9, 9.2 ± 0.5, and 11.7 ± 1.2, and 43.7 ± 6.4, 24.8 ± 1.6, and 26.1 ± 2.4 μM, respectively. Potency and maximal efficacy of propofol, methyl 6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate, pentobarbital, and steroids, 5α-pregnan-3α-ol-20-one and 5β-pregnan-3α-ol-20-one, were unaffected by the β isoform present in the receptor complex. However, several compounds displayed β2/3 subunit selectivity, notably loreclezole, R(–)-etomidate, and a group of anti-inflammatory agents including mefenamic acid, flufenamic acid, meclofenamic acid, tolfenamic acid, niflumic acid, and diflunisal. The anti-inflammatories exhibited varying levels of efficacy at β2/3 subunits, with micromolar potency, while having antagonist or weak inverse agonist profiles at α1β1γ2. Diflunisal was the most efficacious compound, eliciting greater potentiation than loreclezole (90 ± 14% and 109 ± 14% at β3 and β2, respectively, compared with 62 ± 6% and 56 ± 3%), whereas niflumic acid exhibited the lowest efficacy. An additional agent, olsalazine, weakly potentiated responses at all three receptors without any selectivity. This study identifies and characterizes a variety of allosteric modulators for which βsubunits are an important determinant of efficacy and potency.
Footnotes
-
doi:10.1124/jpet.104.070342.
-
ABBREVIATIONS: FRET, fluorescence resonance energy transfer; DMEM, Dulbecco's modified Eagle's medium; CC2-DMPE, chlorocoumarin-2-dimyristoyl phosphatidylethanolamine; DiSBAC2(3), bis(1,3-diethyl-2-thiobarbiturate)trimethineoxonol; THIP, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol; P4S, piperidine-4-sulfonic acid.
- Received April 20, 2004.
- Accepted June 10, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|